Chronic Respiratory Disease

Chronic Respiratory Disease

2015 Impact Factor: 1.646
2015 Ranking: 43/58 in Respiratory System
2016 Release of Journal Citation Reports, Source: 2015 Web of Science Data

Mike Morgan Glenfield Hospital, Leicester, UK
Carolyn Rochester Yale University School of Medicine, USA
Sally Singh Glenfield Hospital, Leicester, UK

eISSN: 14799731 | ISSN: 14799723 | Current volume: 13 | Current issue: 3 Frequency: Quarterly

From January 2017, Chronic Respiratory Disease will publish all new content open access. Therefore, articles first submitted on or after 1st September 2016 will be subject to an open access article process charge (APC), if accepted after peer review. An introductory APC of 1,000 USD, discounted from the full rate of 2,000 USD, is available for a limited time. Authors paying the APC will enjoy the benefits of immediate, full open access publishing and will utilize one of the Creative Commons licenses which enable them to retain copyright.

An example of how this should look is the AVC description page.

Chronic Respiratory Disease is a peer reviewed scholarly journal, created in response to the rising incidence of chronic respiratory diseases worldwide.

It publishes high quality research papers and original articles that have immediate relevance to clinical practice and its multi-disciplinary perspective reflects the nature of modern treatment. The journal provides a high quality, multi-disciplinary focus for the publication of original papers, reviews and commentary in the broad area of chronic respiratory disease, particularly its treatment and management.

Topics covered include:

  • chronic disease areas such as COPD (chronic obstructive pulmonary disease)
  • respiratory failure, bronchiectasis and obstructive sleep apnoea.
  • The content of published articles may include mechanisms of disease but more emphasis is to be placed on the assessment and delivery of patient care.

Chronic Respiratory Disease is of interest to:

  • Respiratory and pulmonary disease specialists
  • Clinical practitioners in both hospital and community settings
  • Respiratory and physical therapists
  • Rehabilitation and care co-ordinators
  • Nurses

This journal is a member of the Committee on Publication Ethics (COPE).

Submit your manuscript today at

Chronic Respiratory Disease is a peer reviewed scholarly journal, created in response to the rising incidence of chronic respiratory diseases worldwide. It publishes high quality research papers and original articles that have immediate relevance to clinical practice and its multi-disciplinary perspective reflects the nature of modern treatment. The journal provides a high quality, multi-disciplinary focus for the publication of original papers, reviews and commentary in the broad area of chronic respiratory disease, particularly its treatment and management.

Topics covered include:

  • chronic disease areas such as COPD (chronic obstructive pulmonary disease)
  • respiratory failure, bronchiectasis and obstructive sleep apnoea.

The content of published articles may include mechanisms of disease but more emphasis is to be placed on the assessment and delivery of patient care.

Chronic Respiratory Disease is of interest to:

  • Respiratory and pulmonary disease specialists
  • Clinical practitioners in both hospital and community settings
  • Respiratory and physical therapists
  • Rehabilitation and care co-ordinators
  • Nurses
Editorial Manager
Shirley Letts Glenfield General Hospital, UK
Editorial Board
Nicolino Ambrosino University of Pisa, Italy
Jean Bourbeau Montreal Chest Institute, Canada
Michelle Cloutier Connecticut Children's Medical Center, USA
Mary Dixon-Woods University of Leicester, UK
Frode Gallefoss SSK, Norway
Dorota Górecka Institute of Tuberculosis and Lung Disease, Warsaw, Poland
Ruth Green Glenfield Hospital, UK
Nicholas Hill Tufts University, USA
Michael E Hyland University of Plymouth, UK
Jose Jardim São Paulo, Brazil
Sue Jenkins Curtin University of Technology, Australia
Peter Lange H S Hvidovre Hospital, Denmark
Suzanne Lareau University of Colorado Denver, USA
Nancy Kline Leidy MEDTAP International Inc., Bethseda, USA
Francois Maltais Laval University, Canada
Paula M. Meek University of Colorado, USA
Linda Nici Brown University, USA
Koichi Nishimura Kyoto-Katsura Hospital, Japan
Ian Town Christchurch School of Medicine & Health Sciences, New Zealand
Thierry Troosters U.Z. Gasthuisberg, Leuven, Belgium
Cees Van Der Schans Hanzehogeschool Groningen, The Netherlands
Emile Wouters University Hospital Maastricht, Netherlands
Richard Zuwallack St Francis Hospital, USA
  • EMBASE/Excerpta Medica
  • Index Medicus
  • Index Medicus (Ceased 2004)
  • SciVal
  • Science Direct Navigator
  • Scopus
    1. Open Access
    2. Article Processing Charge
    3. Article types
    4. Editorial Policies
      4.1 Peer review policy
      4.2 Authorship
      4.3 Acknowledgments
      4.4 Funding
      4.5 Declaration of conflicting interests
      4.6 Research ethics and patient consent
      4.7 Clinical Trials
      4.8 Reporting Guidelines
      4.9 Data
    5. Publishing Policies
      5.1 Publication Ethics
      5.2 Contributor's publishing agreement
      5.3 Permissions
    6. Preparing your manuscript
      6.1 Word processing formats
      6.2 Artwork, figures and other graphics
      6.3 Supplementary material
      6.4 Journal layout
      6.5 Reference style
      6.6 English language editing services
    7. Submitting your manuscript
      7.1 How to submit your manuscript
      7.2 Title, keywords and abstracts
      7.3 Corresponding author contact details
    8. On acceptance and publication
      8.1 SAGE Production
      8.2 Continuous Publication 
    9. Further Information

    This Journal is a member of the Committee on Publication Ethics
    This Journal recommends that authors follow the Uniform Requirements for Manuscripts Submitted to Biomedical Journals formulated by the International Committee of Medical Journal Editors (ICMJE)

    There are no fees payable to submit or publish in this journal.

    Please read the guidelines below then visit the Journal’s submission site to upload your manuscript. Please note that manuscripts not conforming to these guidelines may be returned.

    Only manuscripts of sufficient quality that meet the aims and scope of Chronic Respiratory Disease will be reviewed.

    As part of the submission process you will be required to warrant that you are submitting your original work, that you have the rights in the work, that you are submitting the work for first publication in the Journal and that it is not being considered for publication elsewhere and has not already been published elsewhere, and that you have obtained and can supply all necessary permissions for the reproduction of any copyright works not owned by you.

    Chronic Respiratory Disease publishes original articles, reviews and correspondence on any subject relevant to chronic respiratory care. The journal particularly encourages papers of interdisciplinary authorship. The principal criteria for acceptance of material are originality and quality. All material submitted for publication is assumed to be submitted exclusively to Chronic Respiratory Disease unless the contrary is stated. Before acceptance, papers will be refereed and may be statistically assessed.

    1. Open Access

    Chronic Respiratory Disease is an open access, peer-reviewed journal. Each article accepted by peer review is made freely available online immediately upon publication, is published under a Creative Commons license and will be hosted online in perpetuity. Publication costs of the journal are covered by the collection of article processing charges which are paid by the funder, institution or author of each manuscript upon acceptance. There is no charge for submitting a paper to the journal.

    For general information on open access at SAGE please visit the Open Access page or view our Open Access FAQs.

    Back to top

    2. Article processing charge (APC)

    If, after peer review, your manuscript is accepted for publication, a one-time article processing charge (APC) is payable. This APC covers the cost of publication and ensures that your article will be freely available online in perpetuity under a Creative Commons licence.

    An introductory article processing charge (APC) of $1000 is discounted from the full rate of $2000 is available for a limited time.

    *If the paying party is based in the European Union, to comply with European law, value added tax (VAT) must be added to the APC. Providing a VAT registration number will allow an institution to be exempt from paying this tax, except for UK institutions.

    Back to top

    3. Article types

    Manuscripts are considered for publication with the understanding that they have not been published previously and are not under consideration by another publication.

    The journal publishes original papers, reviews and correspondence.

    Summary of manuscript structure:

    Please double-space the text and references and leave generous margins at head, foot and left- and right-hand margins. All pages must be numbered. Do not paste figures and tables into the text - they should appear at the end of the paper.

    Headings: In dividing articles under headings, please grade the headings by writing A, B, or C in the margin:
    A - subheading
    B - subsubheading
    C - subsubsubheading

    Manuscripts should be approximately as follows:

    Review articles, 4000-5000 words plus references; 
    Original papers, 2000-3000 words plus references, with up to six tables or figures; 
    Editorials, up to 800 words plus references; 
    Pro/con debates, up to 500 words plus references; 
    What the papers say, 500-1000 words plus references; 
    Review of the guidelines, 500-1000 words plus references; 
    Hot topic, up to 1000 words plus references; 
    Technical notes, 500-1000 words plus references; 
    Letters, including Research Letters, up to 600 words plus 2/3 references and 2/3 illustrations/tables;
    Book reviews, 300-500 words plus references; 
    Web reviews, 300-500 words plus references

    Scientific papers should be divided into a structured abstract that uses the headings 'Background, Methods, Results, Conclusions', introduction, methods, results, discussion, acknowledgements, and references. Authors bear sole responsibility for the accuracy of such abstracts.

    Original papers
    Should include:

    • Title page: (1) title of the article; (2) first name(s) or initial(s) and surname of each author; (3) address of the department or institution to which the work should be attributed; (4) full postal address of each author; (5) name, telephone, email address and fax number of the author responsible for correspondence and to whom requests for offprints should be sent. (This is particularly important where the corresponding author is not the first named author.)
    • Abstract (<200 words): a short inclusive statement suitable for direct electronic abstracting identifying the purpose of the study, key methods, the main results and the main conclusion. Structured abstracts are essential for research and review papers, and should be submitted under the headings: objectives, methods, results, and discussion.
    • Key words: maximum of 6 key words for indexing.
    • Introduction: concise description of background, sufficient for the non-specialist to appreciate the context of the work. Clear statement of the purpose of the study. Authors should avoid obviously partisan selection and quotation of literature.
    • Methods: should demonstrate a clear and documented design or strategy directed towards a specific research question. The study design should be appropriate to the aims of the study and be clearly described. The criteria for selecting the sample should be clearly described and justified. A clear description of sampling, recruitment to the study, data collection, and data analysis should be provided. Full details of interventions should be given for intervention studies. This section should also include details of approval from a named Research Ethics Committee, and any arrangements for data oversight.
    • Results: should contain all the information required by referees and readers to assess the validity of the conclusions. The characteristics of the sample included in the study should be clearly described. For quantitative studies, the section should include details of the response rates and numbers lost to follow-up. The analysis should be clear and systematic. Results of statistical tests should be reported with confidence intervals in order to provide an estimate of precision. No more than six tables should be included.
    • Discussion: an interpretation of the study placed within the context of current knowledge leading to specific conclusions where possible. We recommend that this covers the following sections, using sub-headings: summary of main findings; the strengths and the limitations of this study; how and why it agrees or disagrees with the existing literature, in particular including any papers published since the study was designed and carried out; the implications for future research or clinical practice.
    • Each of the above sections should use subheadings as appropriate
    • Acknowledgements.
    • References (ideally max. 25), figures and tables (see 4.5 for more details).

    Generic names should be used for drugs. Authors should be aware of different drug names and availability in the UK, North America and Australia, and give alternative names or drugs in the text.
    (ii) Scientific measurements should be given in SI units, but blood pressure should be expressed in mmHg and haemoglobin as g/dl.
    (iii) For numbers, adopt a rule that all numbers under 10 should be written as words, except when attached to a unit of quantity (e.g. 1 mm or 3 kg), and that numbers of 10 or more should be written as digits, except at the beginning of a sentence.
    (iv) Abbreviations should be kept to a minimum and must be clearly defined when used for the first time. Abbreviations should be typed with no full point.
    (v) Avoid excessive capitalization. For the titles of books and articles, capitals should be used for the initial letter of the first word only. However, for the titles of journals and series, the initial letter of all principal words should be capitalized.
    (vi) Use italics for emphasis only very sparingly.

    Tables should be typed on separate sheets. Indicate in the margin of the text where tables should be positioned. Each table should have an explanatory caption, and be clearly numbered.

    Numbers of patients or subjects should be given, with percentages in brackets. Means should be expressed as the mean with standard deviation of the mean: where appropriate, authors should also consider supplying the median. Care should be taken that all statistical methods are appropriate and that it is clear which methods were used for which analyses. Any statistical methods not in common use should be supported by references or described in detail. Results of statistical tests should be reported as well as the p values; where possible, confidence intervals should also be reported.

    Back to top

     4. Editorial policies

    4.1 Peer review policy

    The journal’s policy is to have manuscripts reviewed by two expert reviewers. Chronic Respiratory Disease utilizes a double-blind peer review process in which the reviewer and author’s names and information are withheld from the other. All manuscripts are reviewed as rapidly as possible, while maintaining rigor. Reviewers make comments to the author and recommendations to the Editor who then makes the final decision.

    As part of the submission process you will be asked to provide the names of peers who could be called upon to review your manuscript. Recommended reviewers should be experts in their fields and should be able to provide an objective assessment of the manuscript. Please be aware of any conflicts of interest when recommending reviewers. Examples of conflicts of interest include (but are not limited to) the below:

    • The reviewer should have no prior knowledge of your submission
    • The reviewer should not have recently collaborated with any of the authors
    • Reviewer nominees from the same institution as any of the authors are not permitted

    Please note that the Editors are not obliged to invite any recommended/opposed reviewers to assess your manuscript.

    The Editor or members of the Editorial Board may occasionally submit their own manuscripts for possible publication in the journal. In these cases, the peer review process will be managed by alternative members of the Board and the submitting Editor / Board member will have no involvement in the decision-making process.

    4.2 Authorship

    Papers should only be submitted for consideration once consent is given by all contributing authors. Those submitting papers should carefully check that all those whose work contributed to the paper are acknowledged as contributing authors.
    The list of authors should include all those who can legitimately claim authorship. This is all those who:

    (i) Made a substantial contribution to the concept or design of the work; or acquisition, analysis or interpretation of data,
    (ii) Drafted the article or revised it critically for important intellectual content,
    (iii) Approved the version to be published,
    (iv) Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content.

    Authors should meet the conditions of all of the points above. Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content.
    When a large, multicentre group has conducted the work, the group should identify the individuals who accept direct responsibility for the manuscript. These individuals should fully meet the criteria for authorship.

    Acquisition of funding, collection of data, or general supervision of the research group alone does not constitute authorship, although all contributors who do not meet the criteria for authorship should be listed in the Acknowledgments section. Please refer to the International Committee of Medical Journal Editors (ICMJE) authorship guidelines for more information on authorship.

    4.3 Acknowledgements

    All contributors who do not meet the criteria for authorship should be listed in an Acknowledgements section. Examples of those who might be acknowledged include a person who provided purely technical help, or a department chair who provided only general support.

    4.3.1 Writing Assistance

    Individuals who provided writing assistance, e.g. from a specialist communications company, do not qualify as authors and so should be included in the Acknowledgements section. Authors must disclose any writing assistance – including the individual’s name, company and level of input – and identify the entity that paid for this assistance.

    It is not necessary to disclose use of language polishing services.

    Please supply any personal acknowledgements separately to the main text to facilitate anonymous peer review.

    4.4 Funding

    Chronic Respiratory Disease requires all authors to acknowledge their funding in a consistent fashion under a separate heading.  Please visit the Funding Acknowledgements page on the SAGE Journal Author Gateway to confirm the format of the acknowledgment text in the event of funding, or state that: This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors. 

    4.5 Declaration of conflicting interests

    It is the policy of Chronic Respiratory Disease to require a declaration of conflicting interests from all authors enabling a statement to be carried within the paginated pages of all published articles.
    Please ensure that a ‘Declaration of Conflicting Interests’ statement is included at the end of your manuscript, after any acknowledgements and prior to the references. If no conflict exists, please state that ‘The Author(s) declare(s) that there is no conflict of interest.’

    For guidance on conflict of interest statements, please see the ICMJE recommendations here

    4.6 Research ethics and patient consent

    Medical research involving human subjects must be conducted according to the World Medical Association Declaration of Helsinki

    Submitted manuscripts should conform to the ICMJE Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, and all papers reporting animal and/or human studies must state in the methods section that the relevant Ethics Committee or Institutional Review Board provided (or waived) approval. Please ensure that you have provided the full name and institution of the review committee, in addition to the approval number.

    For research articles, authors are also required to state in the methods section whether participants provided informed consent and whether the consent was written or verbal.

    Information on informed consent to report individual cases or case series should be included in the manuscript text. A statement is required regarding whether written informed consent for patient information and images to be published was provided by the patient(s) or a legally authorized representative.

    Please also refer to the ICMJE Recommendations for the Protection of Research Participants

    All research involving animals submitted for publication must be approved by an ethics committee with oversight of the facility in which the studies were conducted.

    4.7 Clinical trials

    Chronic Respiratory Disease conforms to the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of first patient enrolment as a condition of consideration for publication. The trial registry name and URL, and registration number must be included at the end of the abstract.

    4.8 Reporting guidelines

    The relevant EQUATOR Network reporting guidelines should be followed depending on the type of study. For example, all randomized controlled trials submitted for publication should include a completed Consolidated Standards of Reporting Trials (CONSORT) flow chart as a cited figure, and a completed CONSORT checklist as a supplementary file.

    Other resources can be found at NLM’s Research Reporting Guidelines and Initiatives

    4.9 Data

    SAGE acknowledges the importance of research data availability as an integral part of the research and verification process for academic journal articles.

    Chronic Respiratory Disease requests all authors submitting any primary data used in their research articles alongside their article submissions to be published in the online version of the journal, or provide detailed information in their articles on how the data can be obtained. This information should include links to third-party data repositories or detailed contact information for third-party data sources. Data available only on an author-maintained website will need to be loaded onto either the journal’s platform or a third-party platform to ensure continuing accessibility. Examples of data types include but are not limited to statistical data files, replication code, text files, audio files, images, videos, appendices, and additional charts and graphs necessary to understand the original research. The editor may consider limited embargoes on proprietary data. The editor can also grant exceptions for data that cannot legally or ethically be released. All data submitted should comply with Institutional or Ethical Review Board requirements and applicable government regulations. For further information, please contact the editorial office at

    Back to top

    5. Publishing policies

    5.1 Publication ethics

    SAGE is committed to upholding the integrity of the academic record. We encourage authors to refer to the Committee on Publication Ethics’ International Standards for Authors and view the Publication Ethics page on the SAGE Author Gateway

    5.1.1 Plagiarism

    Chronic Respiratory Disease and SAGE take issues of copyright infringement, plagiarism or other breaches of best practice in publication very seriously. We seek to protect the rights of our authors and we always investigate claims of plagiarism or misuse of published articles. Equally, we seek to protect the reputation of the journal against malpractice. Submitted articles may be checked with duplication-checking software. Where an article, for example, is found to have plagiarised other work or included third-party copyright material without permission or with insufficient acknowledgement, or where the authorship of the article is contested, we reserve the right to take action including, but not limited to: publishing an erratum or corrigendum (correction); retracting the article; taking up the matter with the head of department or dean of the author’s institution and/or relevant academic bodies or societies; or appropriate legal action.

    5.1.2 Prior publication

    If material has been previously published, it is not generally acceptable for publication in a SAGE journal. However, there are certain circumstances where previously published material can be considered for publication. Please refer to the guidance on the SAGE Author Gateway or if in doubt, contact the Editor at the address given below.

    5.2 Contributor's publishing agreement

    Before publication SAGE requires the author as the rights holder to sign a Journal Contributor’s Publishing Agreement. Chronic Respiratory Disease publishes manuscripts under Creative Commons licenses. The standard Chronic Respiratory Disease license is Creative Commons by Attribution Non-Commercial (CC BY-NC 3.0), which allows others to re-use the work without permission as long as the work is properly referenced and the use is non-commercial. For more information, you are advised to visit SAGE's OA licenses page.

    Alternative license arrangements are available, for example, to meet particular funder mandates, made at the author’s request.

    5.3 Permissions

    Authors are responsible for obtaining permission from copyright holders for reproducing any illustrations, tables, figures or lengthy quotations previously published elsewhere. For further information including guidance on fair dealing for criticism and review, please visit our Frequently Asked Questions on the SAGE Journal Author Gateway

    Back to top

    6. Preparing your manuscript

    6.1 Word processing formats

    Preferred formats for the text and tables of your manuscript are Word DOC, RTF, XLS. LaTeX files are also accepted. The text should be double-spaced throughout and with a minimum of 3cm for left and right hand margins and 5cm at head and foot. Text should be standard 10 or 12 point. Word and (La)Tex templates are available on the Manuscript Submission Guidelines page of our Author Gateway.

    6.2 Artwork, figures and other graphics

    For guidance on the preparation of illustrations, pictures and graphs in electronic format, please visit SAGE’s Manuscript Submission Guidelines.

    Figures supplied in color will appear in color online.

    6.3 Supplementary material

    This journal is able to host additional materials online (e.g. datasets, podcasts, videos, images etc) alongside the full-text of the article. These will be subjected to peer-review alongside the article.  For more information please refer to our guidelines on submitting supplementary files, which can be found within our Manuscript Submission Guidelines page.

    6.4 Journal layout

    Chronic Respiratory Disease conforms to the SAGE house style.  Click here to review guidelines on SAGE UK House Style.

    6.5 Reference style

    Chronic Respiratory Disease adheres to the SAGE Vancouver reference style. Click here to review the guidelines on SAGE Vancouver to ensure your manuscript conforms to this reference style.

    If you use EndNote to manage references, you can download the SAGE Vancouver output file here

    6.6 English language editing services

    Authors seeking assistance with English language editing, translation, or figure and manuscript formatting to fit the journal’s specifications should consider using SAGE Language Services. Visit SAGE Language Services on our Journal Author Gateway for further information.

    Back to top

    7. Submitting your manuscript

    7.1 How to submit your manuscript

    Chronic Respiratory Disease is hosted on SAGE Track, a web based online submission and peer review system powered by ScholarOne™ Manuscripts. Visit to login and submit your article online.

    IMPORTANT: Please check whether you already have an account in the system before trying to create a new one. If you have reviewed or authored for the journal in the past year it is likely that you will have had an account created.  For further guidance on submitting your manuscript online please visit ScholarOne Online Help.

    7.2 Title, keywords and abstracts

    Please supply a title, short title, an abstract and keywords to accompany your article. The title, keywords and abstract are key to ensuring readers find your article online through online search engines such as Google. Please refer to the information and guidance on how best to title your article, write your abstract and select your keywords by visiting the SAGE Journal Author Gateway for guidelines on How to Help Readers Find Your Article Online

    7.3 Corresponding author contact details

    Provide full contact details for the corresponding author including email, mailing address and telephone numbers. Academic affiliations are required for all co-authors. These details should be presented separately to the main text of the article to facilitate anonymous peer review.

    Back to top

    8. On acceptance and publication

    If your paper is accepted for publication after peer review, you will first be asked to complete the contributor’s publishing agreement. Once your manuscript files have been check for SAGE Production, the corresponding author will be asked to pay the article processing charge (APC) via a payment link. Once the APC has been processed, your article will be prepared for publication and can appear online within an average of 30 days. Please note that no production work will occur on your paper until the APC has been received.

    8.1 SAGE Production

    When your paper enters the SAGE Production system, your paper will be issued with a 6 digit ID number. Your SAGE Production Editor will keep you informed as to your article’s progress throughout the production process. Proofs will be sent by email attachment to the corresponding author and should be returned promptly. Authors are reminded to check their proofs carefully to confirm that all author information, including names, affiliations, sequence and contact details are correct, and that Funding and Conflict of Interest statements, if any, are accurate. 

    8.2 Continuous publication

    One of the many benefits of publishing your research in an open access journal is the speed to publication. With no issues to fill and no page count constraints, your article will be published online in a fully citable form with a DOI number as soon as it has completed the production process. At this time it will be completely free to view and download for all. Check the ‘Latest Articles’ tab on the journal website for the latest published content. Articles are batched every quarter, and are then available in the Archive.

    Back to top

    9. Further Information

    Any correspondence, queries or additional requests for information on the manuscript submission process should be sent to the Chronic Respiratory Disease editorial office as follows:

    Shirley Letts
    Editorial Manager

    Back to top